The Eµ-hnRNP K Murine Model of Lymphoma: Novel Insights into the Role of hnRNP K in B-Cell Malignancies
B-cell lymphomas are one of the most biologically and molecularly heterogeneous group of malignancies. The inherent complexity of this cancer subtype necessitates the development of appropriate animal model systems to characterize the disease with the ultimate objective of identifying effective ther...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-04-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.634584/full |
id |
doaj-e1ec8fbf3f81483b8c448576d353cc89 |
---|---|
record_format |
Article |
spelling |
doaj-e1ec8fbf3f81483b8c448576d353cc892021-04-12T05:58:45ZengFrontiers Media S.A.Frontiers in Immunology1664-32242021-04-011210.3389/fimmu.2021.634584634584The Eµ-hnRNP K Murine Model of Lymphoma: Novel Insights into the Role of hnRNP K in B-Cell MalignanciesPrerna Malaney0María Velasco-Estevez1Pedro Aguilar-Garrido2Marisa J. L. Aitken3Lauren E. Chan4Xiaorui Zhang5Sean M. Post6Miguel Gallardo7Department of Leukemia, MD Anderson Cancer Center, Houston, TX, United StatesH12O–CNIO Haematological Malignancies Clinical Research Unit, CNIO, Madrid, SpainH12O–CNIO Haematological Malignancies Clinical Research Unit, CNIO, Madrid, SpainDepartment of Leukemia, MD Anderson Cancer Center, Houston, TX, United StatesDepartment of Leukemia, MD Anderson Cancer Center, Houston, TX, United StatesDepartment of Leukemia, MD Anderson Cancer Center, Houston, TX, United StatesDepartment of Leukemia, MD Anderson Cancer Center, Houston, TX, United StatesH12O–CNIO Haematological Malignancies Clinical Research Unit, CNIO, Madrid, SpainB-cell lymphomas are one of the most biologically and molecularly heterogeneous group of malignancies. The inherent complexity of this cancer subtype necessitates the development of appropriate animal model systems to characterize the disease with the ultimate objective of identifying effective therapies. In this article, we discuss a new driver of B-cell lymphomas – hnRNP K (heterogenous nuclear ribonucleoprotein K)—an RNA-binding protein. We introduce the Eµ-Hnrnpk mouse model, a murine model characterized by hnRNP K overexpression in B cells, which develops B-cell lymphomas with high penetrance. Molecular analysis of the disease developed in this model reveals an upregulation of the c-Myc oncogene via post-transcriptional and translational mechanisms underscoring the impact of non-genomic MYC activation in B-cell lymphomas. Finally, the transplantability of the disease developed in Eµ-Hnrnpk mice makes it a valuable pre-clinical platform for the assessment of novel therapeutics.https://www.frontiersin.org/articles/10.3389/fimmu.2021.634584/fullB-cell malignancieslymphomadiffuse large B cell lymphomamouse modelhnRNP KEµ-Hnrnpk |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Prerna Malaney María Velasco-Estevez Pedro Aguilar-Garrido Marisa J. L. Aitken Lauren E. Chan Xiaorui Zhang Sean M. Post Miguel Gallardo |
spellingShingle |
Prerna Malaney María Velasco-Estevez Pedro Aguilar-Garrido Marisa J. L. Aitken Lauren E. Chan Xiaorui Zhang Sean M. Post Miguel Gallardo The Eµ-hnRNP K Murine Model of Lymphoma: Novel Insights into the Role of hnRNP K in B-Cell Malignancies Frontiers in Immunology B-cell malignancies lymphoma diffuse large B cell lymphoma mouse model hnRNP K Eµ-Hnrnpk |
author_facet |
Prerna Malaney María Velasco-Estevez Pedro Aguilar-Garrido Marisa J. L. Aitken Lauren E. Chan Xiaorui Zhang Sean M. Post Miguel Gallardo |
author_sort |
Prerna Malaney |
title |
The Eµ-hnRNP K Murine Model of Lymphoma: Novel Insights into the Role of hnRNP K in B-Cell Malignancies |
title_short |
The Eµ-hnRNP K Murine Model of Lymphoma: Novel Insights into the Role of hnRNP K in B-Cell Malignancies |
title_full |
The Eµ-hnRNP K Murine Model of Lymphoma: Novel Insights into the Role of hnRNP K in B-Cell Malignancies |
title_fullStr |
The Eµ-hnRNP K Murine Model of Lymphoma: Novel Insights into the Role of hnRNP K in B-Cell Malignancies |
title_full_unstemmed |
The Eµ-hnRNP K Murine Model of Lymphoma: Novel Insights into the Role of hnRNP K in B-Cell Malignancies |
title_sort |
eµ-hnrnp k murine model of lymphoma: novel insights into the role of hnrnp k in b-cell malignancies |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Immunology |
issn |
1664-3224 |
publishDate |
2021-04-01 |
description |
B-cell lymphomas are one of the most biologically and molecularly heterogeneous group of malignancies. The inherent complexity of this cancer subtype necessitates the development of appropriate animal model systems to characterize the disease with the ultimate objective of identifying effective therapies. In this article, we discuss a new driver of B-cell lymphomas – hnRNP K (heterogenous nuclear ribonucleoprotein K)—an RNA-binding protein. We introduce the Eµ-Hnrnpk mouse model, a murine model characterized by hnRNP K overexpression in B cells, which develops B-cell lymphomas with high penetrance. Molecular analysis of the disease developed in this model reveals an upregulation of the c-Myc oncogene via post-transcriptional and translational mechanisms underscoring the impact of non-genomic MYC activation in B-cell lymphomas. Finally, the transplantability of the disease developed in Eµ-Hnrnpk mice makes it a valuable pre-clinical platform for the assessment of novel therapeutics. |
topic |
B-cell malignancies lymphoma diffuse large B cell lymphoma mouse model hnRNP K Eµ-Hnrnpk |
url |
https://www.frontiersin.org/articles/10.3389/fimmu.2021.634584/full |
work_keys_str_mv |
AT prernamalaney theeμhnrnpkmurinemodeloflymphomanovelinsightsintotheroleofhnrnpkinbcellmalignancies AT mariavelascoestevez theeμhnrnpkmurinemodeloflymphomanovelinsightsintotheroleofhnrnpkinbcellmalignancies AT pedroaguilargarrido theeμhnrnpkmurinemodeloflymphomanovelinsightsintotheroleofhnrnpkinbcellmalignancies AT marisajlaitken theeμhnrnpkmurinemodeloflymphomanovelinsightsintotheroleofhnrnpkinbcellmalignancies AT laurenechan theeμhnrnpkmurinemodeloflymphomanovelinsightsintotheroleofhnrnpkinbcellmalignancies AT xiaoruizhang theeμhnrnpkmurinemodeloflymphomanovelinsightsintotheroleofhnrnpkinbcellmalignancies AT seanmpost theeμhnrnpkmurinemodeloflymphomanovelinsightsintotheroleofhnrnpkinbcellmalignancies AT miguelgallardo theeμhnrnpkmurinemodeloflymphomanovelinsightsintotheroleofhnrnpkinbcellmalignancies AT prernamalaney eμhnrnpkmurinemodeloflymphomanovelinsightsintotheroleofhnrnpkinbcellmalignancies AT mariavelascoestevez eμhnrnpkmurinemodeloflymphomanovelinsightsintotheroleofhnrnpkinbcellmalignancies AT pedroaguilargarrido eμhnrnpkmurinemodeloflymphomanovelinsightsintotheroleofhnrnpkinbcellmalignancies AT marisajlaitken eμhnrnpkmurinemodeloflymphomanovelinsightsintotheroleofhnrnpkinbcellmalignancies AT laurenechan eμhnrnpkmurinemodeloflymphomanovelinsightsintotheroleofhnrnpkinbcellmalignancies AT xiaoruizhang eμhnrnpkmurinemodeloflymphomanovelinsightsintotheroleofhnrnpkinbcellmalignancies AT seanmpost eμhnrnpkmurinemodeloflymphomanovelinsightsintotheroleofhnrnpkinbcellmalignancies AT miguelgallardo eμhnrnpkmurinemodeloflymphomanovelinsightsintotheroleofhnrnpkinbcellmalignancies |
_version_ |
1721530304676495360 |